184 related articles for article (PubMed ID: 22365772)
41. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
[TBL] [Abstract][Full Text] [Related]
42. Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer.
Weil WM; Linton GF; Whiting-Theobald N; Vowells SJ; Rafferty SP; Li F; Malech HL
Blood; 1997 Mar; 89(5):1754-61. PubMed ID: 9057660
[TBL] [Abstract][Full Text] [Related]
43. Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.
De Ravin SS; Reik A; Liu PQ; Li L; Wu X; Su L; Raley C; Theobald N; Choi U; Song AH; Chan A; Pearl JR; Paschon DE; Lee J; Newcombe H; Koontz S; Sweeney C; Shivak DA; Zarember KA; Peshwa MV; Gregory PD; Urnov FD; Malech HL
Nat Biotechnol; 2016 Apr; 34(4):424-9. PubMed ID: 26950749
[TBL] [Abstract][Full Text] [Related]
44. Gene therapy for chronic granulomatous disease.
Goebel WS; Dinauer MC
Acta Haematol; 2003; 110(2-3):86-92. PubMed ID: 14583668
[TBL] [Abstract][Full Text] [Related]
45. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
Hanazono Y; Terao K; Ozawa K
Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
[TBL] [Abstract][Full Text] [Related]
46. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease.
Nagler A; Ackerstein A; Kapelushnik J; Or R; Naparstek E; Slavin S
Bone Marrow Transplant; 1999 Aug; 24(3):339-42. PubMed ID: 10455377
[TBL] [Abstract][Full Text] [Related]
47. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
48. [A therapeutic approach towards chronic granulomatous disease].
Kawai T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):437-46. PubMed ID: 25748127
[TBL] [Abstract][Full Text] [Related]
49. Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.
Barde I; Laurenti E; Verp S; Wiznerowicz M; Offner S; Viornery A; Galy A; Trumpp A; Trono D
Gene Ther; 2011 Nov; 18(11):1087-97. PubMed ID: 21544095
[TBL] [Abstract][Full Text] [Related]
50. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
Sadat MA; Dirscherl S; Sastry L; Dantzer J; Pech N; Griffin S; Hawkins T; Zhao Y; Barese CN; Cross S; Orazi A; An C; Goebel WS; Yoder MC; Li X; Grez M; Cornetta K; Mooney SD; Dinauer MC
Gene Ther; 2009 Dec; 16(12):1452-64. PubMed ID: 19657370
[TBL] [Abstract][Full Text] [Related]
51. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
[TBL] [Abstract][Full Text] [Related]
52. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
[TBL] [Abstract][Full Text] [Related]
53. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
54. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.
Åhlin A; Fugeläng J; de Boer M; Ringden O; Fasth A; Winiarski J
Acta Paediatr; 2013 Nov; 102(11):1087-94. PubMed ID: 23937637
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy for chronic granulomatous disease.
Barese CN; Goebel WS; Dinauer MC
Expert Opin Biol Ther; 2004 Sep; 4(9):1423-34. PubMed ID: 15335310
[TBL] [Abstract][Full Text] [Related]
56. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
Goebel WS; Mark LA; Billings SD; Meyers JL; Pech N; Travers JB; Dinauer MC
J Invest Dermatol; 2005 Oct; 125(4):705-10. PubMed ID: 16185269
[TBL] [Abstract][Full Text] [Related]
57. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
[TBL] [Abstract][Full Text] [Related]
58. Retroviral-mediated gene transfer and nonmyeloablative conditioning: studies in a murine X-linked chronic granulomatous disease model.
Goebel WS; Dinauer MC
J Pediatr Hematol Oncol; 2002 Dec; 24(9):787-90. PubMed ID: 12468930
[TBL] [Abstract][Full Text] [Related]
59. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.
Zou J; Sweeney CL; Chou BK; Choi U; Pan J; Wang H; Dowey SN; Cheng L; Malech HL
Blood; 2011 May; 117(21):5561-72. PubMed ID: 21411759
[TBL] [Abstract][Full Text] [Related]
60. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
